Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator–activated receptor delta (PPARδ) is a nuclear hormone receptor that functions as a ligand-dependent transcription factor. It regulates genes involved in lipid and glucose metabolism, cellular differentiation, inflammation, and other processes. Activated by fatty acids and eicosanoids, it forms heterodimers with RXRs to bind PPREs and modulate gene expression. PPARδ plays roles in metabolic regulation, cardiovascular function, and potentially cancer, with studies showing conflicting evidence for its role in tumor progression.
Upon ligand binding, PPARδ forms heterodimers with retinoid X receptors (RXRs). This complex binds to specific DNA sequences called peroxisome-proliferator response elements (PPREs) within target gene promoters to regulate transcription.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome proliferator–activated receptor delta (PPARδ).